Bergenbio Asa

This study tested whether adding a new drug called bemcentinib (BGB324) to an existing immunotherapy (pembrolizumab) could help control advanced lung cancer that had worsened after prior treatment. It involved 99 adults with a specific type of lung cancer (adenocarcinoma) whose d…